Abiopharma

Coherent Launches Compact, Air-Cooled Diode Laser System and Sets New Standard in Polymer Welding

Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization

Johnson & Johnson Launches VOLT™ Wrist and Proximal Humerus Plating Systems in the U.S.

Auxly Announces Non-Binding Agreement to Amend and Extend BMO Credit Facility and Settlement of all Amounts owing to Imperial Brands

Castle Biosciences - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zomedicas Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance

Financial Statements and Related Announcement: Notification of Results Release

Insulet - Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Change in interest of Substantial Shareholders - Wong Kong Leong

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

General Announcement: DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS): DEALINGS OUTSIDE CLOSED PERIOD

Incyte annonce l’autorisation de Monjuvi® (tafasitamab-cxix) par la FDA en combinaison avec rituximab et lénalidomide pour les patients souffrant de lymphome folliculaire en rechute ou réfractaire